PhRMA Launches New Suit Over 340B Orphan Drug Rule
Reviving a high-stakes fight, Pharmaceutical Research and Manufacturers of America on Thursday sued the U.S. Department of Health and Human Services in D.C. federal court to prevent regulators from disciplining drugmakers...To view the full article, register now.
Already a subscriber? Click here to view full article